Share buyback completed. Total shares acquired: 344,200 shares, representing 5.17% of issued shares, total acquisition amount: 686,679,000 yen. Target shares are common stock. Completion of acquisition date and the upper limit resolution, acquisition conducted via ToSTNeT-3.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6678","jir_company_name":"TechnoMedica Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/6678-20260806-01.pdf","jir_short_summary":"Share buyback completed. Total shares acquired: 344,200 shares, representing 5.17% of issued shares, total acquisition amount: 686,679,000 yen. Target shares are common stock. Completion of acquisition date and the upper limit resolution, acquisition conducted via ToSTNeT-3.","jir_summary":"### Background and overview of the acquisition\nToday, we conducted the share buyback and completed it in accordance with the Board of Directors' resolution. The acquisition targets are common stock, the method is off-market purchase via ToSTNeT-3, and the period is as of August 6, 2026. The total acquisition amount is 686,679,000 yen, the total number of shares is 344,200, and the portion of issued shares is 5.17%.\n\n### Upper limit and resolution\nIn the resolution disclosed on August 5, 2026, the maximum number of shares that could be acquired was 350,000 shares (upper limit of 5.25% of issued shares). The acquisitions conducted this time were within this upper limit and have been completed.","jir_financial_highlights":"Total number of shares acquired: 344,200 shares (Unknown)\nTotal amount of shares acquired: 686,679,000 yen (Unknown)\nProportion of issued shares: 5.17% (Unknown)","jir_category":"","jir_hashtags":"#TechnoMedica_Share Buyback Completed, #Capital Efficiency Improvement","jir_key_figures":"344,200 shares: Total number of shares acquired (5.17%)\n686,679,000 yen: Total amount of shares acquired\n350,000 shares: Acquisition upper limit (5.25%)","jir_meta_title":"TechnoMedica Co., Ltd. completes share buyback | 344,200 shares, 5.17%, 6,8679 million yen, ToSTNeT-3","jir_meta_description":"TechnoMedica Co., Ltd. announces the results and completion of its share buyback. Shares acquired: 344,200 shares, 5.17%, total amount 6,867,900 yen, via ToSTNeT-3. Upper resolution limit: 350,000 shares, 5.25%.","jir_og_title":"TechnoMedica Co., Ltd. completes share buyback | 344,200 shares, 5.17%, 6,8679 million yen","jir_og_description":"TechnoMedica completes its share buyback. Discloses number of shares, amount, and ratio. Completion upon reaching the upper limit.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57947,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-95984","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n